Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.84 is 62% above its 5-year average of -2.22, around the middle of its 5-year range (-4.53–1.51).
75.29% above its 12-month average of -3.40.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.36.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 39 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:52:55.906Z. Historical observations retain their original dates. Historical series through 2022-08-08.
EARNINGS PER SHARE (EPS)
-0.84
EARNINGS PER SHARE (EPS) AVG TTM
-3.40
EARNINGS PER SHARE (EPS) AVG 3Y
-3.01
EARNINGS PER SHARE (EPS) AVG 5Y
-2.22
EARNINGS PER SHARE (EPS) AVG 10Y
-2.78
EARNINGS PER SHARE (EPS) AVG 15Y
-2.65
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+75.29%
CURRENT VS 3Y AVG
+72.07%
CURRENT VS 5Y AVG
+62.11%
CURRENT VS 10Y AVG
+69.77%
CURRENT VS 15Y AVG
+68.34%
CURRENT VS 20Y AVG
N/A
Prothena Corporation plc
Market Cap
$411.62M
Earnings Per Share (EPS)
-0.84
TTM Avg
-3.40
3Y Avg
-3.01
5Y Avg
-2.22
Market Cap
$411.79M
Earnings Per Share (EPS)
-1.19
TTM Avg
-2.69
3Y Avg
-2.49
5Y Avg
-2.21
Market Cap
$412.30M
Earnings Per Share (EPS)
0.50
TTM Avg
0.08
3Y Avg
-0.25
5Y Avg
-0.31
Market Cap
$409.24M
Earnings Per Share (EPS)
-0.76
TTM Avg
-0.86
3Y Avg
-1.02
5Y Avg
-1.51
Market Cap
$415.43M
Earnings Per Share (EPS)
-2.27
TTM Avg
-2.08
3Y Avg
-0.07
5Y Avg
-5.01
Market Cap
$407.71M
Earnings Per Share (EPS)
-1.71
TTM Avg
-1.36
3Y Avg
-1.12
5Y Avg
-1.12
Market Cap
$407.12M
Earnings Per Share (EPS)
-4.63
TTM Avg
-6.16
3Y Avg
-6.16
5Y Avg
-6.16
Market Cap
$407.02M
Earnings Per Share (EPS)
-5.51
TTM Avg
-4.26
3Y Avg
-3.91
5Y Avg
-2.87
Market Cap
$403.70M
Earnings Per Share (EPS)
-1.36
TTM Avg
-1.81
3Y Avg
-2.62
5Y Avg
-2.62
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Prothena Corporation plc (PRTA) | $411.62M | -0.84 | -3.40 | -3.01 | -2.22 |
| Myriad Genetics, Inc. (MYGN)vs › | $411.79M | -1.19 | -2.69 | -2.49 | -2.21 |
| Strata Critical Medical, Inc. (SRTA)vs › | $412.30M | 0.50 | 0.08 | -0.25 | -0.31 |
| Rezolute, Inc. (RZLT)vs › | $409.24M | -0.76 | -0.86 | -1.02 | -1.51 |
| Senseonics Holdings, Inc. (SENS)vs › | $415.43M | -2.27 | -2.08 | -0.07 | -5.01 |
| Shoulder Innovations, Inc. (SI)vs › | $407.71M | -1.71 | -1.36 | -1.12 | -1.12 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $407.12M | -4.63 | -6.16 | -6.16 | -6.16 |
| Neurogene Inc. (NGNE)vs › | $407.02M | -5.51 | -4.26 | -3.91 | -2.87 |
| Carlsmed, Inc. (CARL)vs › | $403.70M | -1.36 | -1.81 | -2.62 | -2.62 |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $402.33M | -2.08 | -1.97 | -1.74 | -0.94 |
Trailing EPS (TTM)
$-0.84
Forward EPS (Est.)
$0.11
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -4.53 |
| 2024-12-31 | -2.27 |
| 2023-12-31 | -2.76 |
| 2022-12-31 | -2.47 |
| 2021-12-31 | 1.51 |
| 2020-12-31 | -2.78 |
| 2019-12-31 | -1.95 |
| 2018-12-31 | -3.93 |
| 2017-12-31 | -4.07 |
| 2016-12-31 | -4.66 |
| 2015-12-31 | -2.66 |
| 2014-12-31 | -0.29 |
| 2013-12-31 | -2.20 |
| 2012-12-31 | -2.84 |
| 2011-12-31 | -1.68 |
| 2010-12-31 | -0.71 |
